journal article·2019-11-20

BHQ-Cyanine-Based “Off–On” Long-Circulating Assembly as a Ferroptosis Amplifier for Cancer Treatment: A Lipid-Peroxidation Burst Device

Mangmang Sang, Renjie Luo, Yidan Bai, Jun Dou, Zhongtao Zhang, Fulei Liu, Feng Feng, Wenyuan Liu

ACS Applied Materials & Interfaces· Volume 11· Issue 46
Publisher page

Abstract

Ferroptosis is an iron-dependent cell death caused by accumulation of lipid peroxidation (LPO), which is a new strategy for cancer treatment. Th current ferroptosis therapy nanodevices have low efficiency and side effects generally. Hence, we developed a Black Hole Quencher (BHQ)-based fluorescence "off-on" nanophotosensitizer complex assembly (CSO-BHQ-IR780-Hex/MIONPs/Sor). CSO-connected BHQ-IR780-Hex and -loaded magnetic iron oxide nanoparticles (MIONPs) and sorafenib (Sor) formed a very concise functionalized delivery system. CSO-BHQ-IR780-Hex disassembled by GSH attack and released IR780-Hex, MIONPs, and sorafenib. IR780-Hex anchored to the mitochondrial membrane, which would contribute to amplifying the efficiency of the photosensitizer. When NIR irradiation was given to CSO-BHQ-IR780-Hex/MIONPs/Sor-treated cells, iron supply increased, the xCT/GSH/GPX-4 system was triggered, and a lot of LPO burst. A malondialdehyde test showed that LPO in complex assembly-treated cells was explosive and increased about 18-fold compared to the control. The accumulation process of particles was monitored by an IR780-Hex photosensitizer, which showed an excellent tumor target ability by magnetic of nanodevice in vivo. Interestingly, the half-life of sorafenib in a nanodevice was increased about 26-fold compared to the control group. Importantly, the complex assembly effectively inhibits tumor growth in the breast tumor mouse model. This work would provide ideas in designing nanomedicines for the ferroptosis treatment of cancer.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Ferroptosis and cancer prognosis · Nanoplatforms for cancer theranostics · Immune cells in cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing 210009, China

Department of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, China

Jiangsu Food & Pharmaceutical Science College, 4 Meicheng Donglu, Huaian 223003, China

Hangzhou Institute of Pharmaceutical Innovation, China Pharmaceutical University, 291 Fucheng Lu, Hangzhou 310018, China

Funding

Natural Science Foundation of Jiangsu Province · National Natural Science Foundation of China

References (33)

Show source-provided references
1. 10.1016/j.cell.2012.03.04210.1016/j.cell.2012.03.042 ↗
2. 10.1038/nature0585910.1038/nature05859 ↗
3. 10.1016/j.ceb.2009.12.00310.1016/j.ceb.2009.12.003 ↗
4. 10.1038/374814a010.1038/374814a0 ↗
5. 10.1038/nature2300710.1038/nature23007 ↗
6. 10.1016/j.cell.2012.03.04210.1016/j.cell.2012.03.042 ↗
7. 10.1016/s1535-6108(03)00050-310.1016/s1535-6108(03)00050-3 ↗
8. 10.3322/caac.2011410.3322/caac.20114 ↗
9. 10.1016/s1470-2045(04)01620-110.1016/s1470-2045(04)01620-1 ↗
10. 10.1021/acsnano.8b0586010.1021/acsnano.8b05860 ↗
11. 10.7150/thno.3628310.7150/thno.36283 ↗
12. 10.1021/ja500962u10.1021/ja500962u ↗
13. 10.1021/acsnano.5b0450110.1021/acsnano.5b04501 ↗
14. 10.1016/j.apcatb.2016.01.01510.1016/j.apcatb.2016.01.015 ↗
15. 10.1016/j.cell.2013.12.01010.1016/j.cell.2013.12.010 ↗
16. 10.1016/j.cell.2017.09.02110.1016/j.cell.2017.09.021 ↗
17. 10.1016/j.actbio.2017.12.02810.1016/j.actbio.2017.12.028 ↗
18. 10.1021/acschembio.7b0093910.1021/acschembio.7b00939 ↗
19. 10.1021/ja500962u10.1021/ja500962u ↗
20. 10.1166/jbn.2018.254110.1166/jbn.2018.2541 ↗
21. 10.1080/10717544.2018.148647210.1080/10717544.2018.1486472 ↗
22. 10.1016/j.biomaterials.2013.09.00110.1016/j.biomaterials.2013.09.001 ↗
23. 10.1016/j.biomaterials.2012.09.04410.1016/j.biomaterials.2012.09.044 ↗
24. 10.1021/cb500986w10.1021/cb500986w ↗
25. 10.1002/hep.2825110.1002/hep.28251 ↗
26. 10.1016/j.cell.2013.12.01010.1016/j.cell.2013.12.010 ↗
27. 10.1021/ja500962u10.1021/ja500962u ↗
28. 10.1038/nature0731110.1038/nature07311 ↗
29. 10.1021/acschembio.7b0093910.1021/acschembio.7b00939 ↗
30. 10.1096/fj.11-20189710.1096/fj.11-201897 ↗
31. 10.1038/nchembio.223810.1038/nchembio.2238 ↗
32. 10.1016/j.tcb.2015.10.01410.1016/j.tcb.2015.10.014 ↗
33. 10.1038/cdd.2015.15810.1038/cdd.2015.158 ↗